LENZ Therapeutics LENZ
NASDAQ LENZ
$4.73 +0.07 (+1.50%)
As of: Aug 21, 2026 · 1:32 PM EDT

LENZ Therapeutics (LENZ) FCF Margin (QoQ) (2025 - 2026)

LENZ Therapeutics (LENZ) FCF Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.35 Bn 131.50 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.12 Bn 78.12 Bn 3.93 Bn
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn
4 Moderna 58.98 Bn 53.84 Bn 52.00 Mn
5 BeOne Medicines 42.08 Bn 36.99 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 27.98 Bn 9.59 Bn 668.28 Mn
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
9 Royalty Pharma 27.30 Bn 26.47 Bn -
10 LENZ Therapeutics 148.87 Mn 148.87 Mn 5.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 106,153.00
Mar 31, 2026 -202,438.00
Dec 31, 2025 33,127.00
Sep 30, 2025 15,866.00